$Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant$

Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant

Abstract Background There is paucity of data regarding outcomes of children, adolescents and young adults (CAYA) patients with non-Hodgkin lymphoma (NHL) undergoing autologous stem cell transplantation (ASCT). Methods Patients aged 0–39 years undergoing first ASCT for NHL at MD Anderson Cancer Cente...

Full description

Bibliographic Details
Main Authors:	Oren Pasvolsky, Roland L. Bassett, Sassine Ghanem, Branko Cuglievan, Priti Tewari, Chitra Hosing, Samer Srour, Jeremy Ramdial, Kris M. Mahadeo, Sajad Khazal, Demetrios Petropoulos, Uday Popat, Muzaffar Qazilbash, Partow Kebriaei, Richard Champlin, Elizabeth J. Shpall, Yago Nieto
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Series:	BMC Cancer
Subjects:	Non hodgkin lymphoma Children Adolescents Young adults Autologous transplant
Online Access:	https://doi.org/10.1186/s12885-023-11712-6

Similar Items

P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES
by: Oren Pasvolsky, et al.
Published: (2023-08-01)

Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
by: Irtiza N. Sheikh, et al.
Published: (2022-08-01)

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy
by: Francesco Paolo Tambaro, et al.
Published: (2020-09-01)

Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
by: Oren Pasvolsky, et al.
Published: (2024-01-01)

P1299: OUTCOMES OF YOUNG ADULTS (AGED ≤40 YEARS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANT
by: Oren Pasvolsky, et al.
Published: (2023-08-01)

P1303: DARATUMUMAB-BASED MAINTENANCE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AFTER SALVAGE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Oren Pasvolsky, et al.
Published: (2023-08-01)

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients
by: Oren Pasvolsky, et al.
Published: (2023-05-01)

The role of allogeneic stem cell transplantation in the therapy of adult acute lymphoblastic leukemia O papel do transplante alogênico de células progenitoras na terapia de leucemia linfoblástica aguda em adultos
by: Partow Kebriaei, et al.
Published: (2005-03-01)

P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
by: Uday R. Popat, et al.
Published: (2023-08-01)

P1376: LENALIDOMIDE–BASED MAINTENANCE AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK MULTIPLE MYELOMA
by: O. Pasvolsky, et al.
Published: (2022-06-01)

Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
by: Faryal Munir, et al.
Published: (2023-06-01)

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
by: Uri Greenbaum, et al.
Published: (2020-08-01)

Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
by: Brandon Douglas Brown, et al.
Published: (2021-03-01)

The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
by: Dristhi Ragoonanan, et al.
Published: (2022-09-01)

Transfusion reactions in pediatric and adolescent young adult haematology oncology and immune effector cell patients
by: Mira A. Kohorst, et al.
Published: (2020-09-01)

Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
by: Irtiza N. Sheikh, et al.
Published: (2021-11-01)

Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
by: Harjeet Singh, et al.
Published: (2022-11-01)

A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy
by: Dristhi Ragoonanan, et al.
Published: (2022-10-01)

Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
by: Avis Harden, et al.
Published: (2020-08-01)

Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells
by: Benigno C. Valdez, et al.
Published: (2023-11-01)

Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
by: Irtiza N. Sheikh, et al.
Published: (2022-06-01)

The Organ Trail: A Review of Biomarkers of Organ Failure
by: Long Dao, et al.
Published: (2020-11-01)

Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials
by: Rohtesh S Mehta, et al.
Published: (2015-12-01)

Modeling of metal forming and machining processes : by finite element and soft computing methods /
by: 420212 Dixit, Prakash Mahadeo, et al.
Published: (2008)

P657: PATHOGENESIS OF TYROSINE KINASE INHIBITOR–ASSOCIATED VASCULAR TOXICITY IN CHRONIC MYELOID LEUKEMIA
by: Ayala Gover Proaktor, et al.
Published: (2023-08-01)

Plasticity : fundamentals and applications /
by: Dixit, Prakash Mahadeo author, et al.
Published: (2015)

Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells.
by: Harjeet Singh, et al.
Published: (2013-01-01)

Secondary monoclonal gammopathy of unknown significance with isotype switching after CAR T-cell therapy for multiple myeloma: A case report
by: Nilesh M. Kalariya, et al.
Published: (2024-03-01)

Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability
by: Ajay Sheshadri, et al.
Published: (2022-02-01)

Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option
by: Jiasen He, et al.
Published: (2023-01-01)

Central nervous system Langerhans cell histiocytosis and neurodegenerative syndrome responding to MEK inhibition
by: Andrew Wahba, et al.
Published: (2021-11-01)

Implementing Rounding Checklists in a Pediatric Oncologic Intensive Care Unit
by: Mary Katherine Gardner, et al.
Published: (2022-04-01)

Transformation in the national department of public works: a market driven strategy
by: Mahadeo, Mahadeo, et al.
Published: (2008)

Skin biopsies in acute myeloid leukemia patients undergoing intensive chemotherapy are safe and effect patient management
by: Tamar Berger, et al.
Published: (2021-06-01)

Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia
by: Jiasen He, et al.
Published: (2024-02-01)

TRANSFORMING P & O CARE WITH 3D PRINTING– MORE THAN MEETS THE EYE
by: Jan Andrysek, et al.
Published: (2023-12-01)

The spectrum of intraoral bacteria seen in patients with cleft palates in an African setting
by: Shaal Ramdial, et al.
Published: (2019-04-01)

Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies
by: Susan Bal, et al.
Published: (2023-11-01)

Foucault en l’entretien
by: Farés Sassine
Published: (2018-10-01)

Future projections of temperature and precipitation for Antarctica
by: Kamal Tewari, et al.
Published: (2022-01-01)